Skip to main content

  • Impact of First-Phase Ejection Fraction on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation

    • Posted: 09/01/2022
    • Author:

      Daijiro Tomii, Taishi Okuno, Caglayan Demirel, Fabien Praz, Jonas Lanz, Stefan Stortecky, Stephan Windecker and Thomas Pilgrim

    • CRM2022

    Abstract

    Background

    First-phase left ventricular ejection fraction (LVEF1) is an early marker of left ventricular remodeling. Reduced LVEF1 has been associated with adverse prognosis in patients with aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF). It remains to be determined, whether reduced LVEF1 differentiates clinical outcomes after aortic valve replacement.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details